Prestige Consumer Healthcare (NYSE:PBH) is set to release its earnings data before the market opens on Thursday, October 31st. Analysts expect Prestige Consumer Healthcare to post earnings of $0.65 per share for the quarter. Prestige Consumer Healthcare has set its FY 2020 guidance at $2.76-2.83 EPS and its FY20 guidance at $2.76-2.83 EPS.Persons that are interested in participating in the company’s earnings conference call can do so using this link.
Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, August 1st. The company reported $0.65 EPS for the quarter, topping the consensus estimate of $0.64 by $0.01. Prestige Consumer Healthcare had a negative net margin of 3.81% and a positive return on equity of 12.45%. The company had revenue of $232.15 million for the quarter, compared to the consensus estimate of $231.52 million. During the same period in the previous year, the firm earned $0.68 earnings per share. The firm’s revenue for the quarter was down 8.6% on a year-over-year basis. On average, analysts expect Prestige Consumer Healthcare to post $3 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Shares of NYSE PBH opened at $35.11 on Tuesday. The company has a quick ratio of 1.26, a current ratio of 2.16 and a debt-to-equity ratio of 1.63. Prestige Consumer Healthcare has a 52 week low of $26.25 and a 52 week high of $41.76. The firm’s fifty day moving average is $34.83 and its 200 day moving average is $31.98. The company has a market cap of $1.81 billion, a price-to-earnings ratio of 12.63, a PEG ratio of 1.93 and a beta of 0.89.
Several brokerages recently commented on PBH. ValuEngine raised shares of Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a research report on Friday, July 26th. TheStreet raised shares of Prestige Consumer Healthcare from a “d+” rating to a “c-” rating in a research report on Tuesday, July 23rd. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the stock. Prestige Consumer Healthcare has an average rating of “Hold” and an average target price of $61.07.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.
Read More: What is a back-end load?
Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.